23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Elanco Animal Health Incorporated › 2025-2026

Elanco Animal Health Incorporated 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Elanco Animal Health Incorporated’s Form 8-K, filed May 27, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 7Ballot items
  • 501Asset managers, any item
  • 4,257Fund votes
  • May 21, 2026Meeting date

Results at a glance

Meeting of May 21, 2026: 7 items on Elanco Animal Health Incorporated’s Form 8-K, filed May 27, 2026: 5 elected · 2 approved.

Dissent

Significant dissent: 1 director (20.2% against).

Notable dissent: 1 director (19.7% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Elanco Animal Health Incorporated in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Elanco Animal Health Incorporated

These tallies are Elanco Animal Health Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Elanco Animal Health Incorporated — official shareholder meeting results, meeting held May 21, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Kapila K. Anand 375,459,07191,840,502655,918 --15,365,167 80%Elected—
Elect Director: Paul Herendeen 441,252,05826,575,629127,804 --15,365,167 94%Elected—
Elect Director: Michael Harrington 373,406,33394,421,261127,897 --15,365,167 80%Elected—
Elect Director: Lawrence Kurzius 442,964,89724,863,542127,052 --15,365,167 95%Elected—
Elect Director: Kirk McDonald 440,842,45826,978,663134,370 --15,365,167 94%Elected—
2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026 480,470,6472,611,450238,561 ---- 99.5%Approved—
3. By non-binding vote, the compensation of Elanco's named executive officers 383,528,22284,173,798253,471 --15,365,167 82%Approved—

Source: Elanco Animal Health Incorporated, Form 8-K, filed with the SEC on May 27, 2026 — read the filing on EDGAR.

How asset managers voted at the Elanco Animal Health Incorporated 2025-2026 meeting

501 asset managers disclosed a vote on at least one Elanco Animal Health Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Kapila K. Anand

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST
FOR: 375,459,071AGAINST: 91,840,502

Prior year: 65.8% for (May 16, 2025 meeting) ▲ 14.5 pts

Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kapila K. Anand”): 375,459,071 for, 91,840,502 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 227,799,590 for, 60,795,821 against, 82,174 abstained, 419 not voted.

FORAGAINST
FOR: 227,799,590AGAINST: 60,795,821ABSTAIN: 82,174NOT VOTED: 419
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,607,95255,461 10For
Dodge & Cox053,024,253 00Against
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).

Elect Director: Paul Herendeen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 441,252,058AGAINST: 26,575,629

Prior year: 94.5% for (May 16, 2025 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herendeen

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Paul Herendeen”): 441,252,058 for, 26,575,629 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 280,823,991 for, 7,771,421 against, 82,173 abstained, 419 not voted.

FOR
FOR: 280,823,991AGAINST: 7,771,421ABSTAIN: 82,173NOT VOTED: 419
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herende” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,10055,314 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).

Elect Director: Kirk McDonald

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 440,842,458AGAINST: 26,978,663
Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDonald

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kirk McDonald”): 440,842,458 for, 26,978,663 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 280,823,991 for, 7,771,421 against, 82,173 abstained, 419 not voted.

FOR
FOR: 280,823,991AGAINST: 7,771,421ABSTAIN: 82,173NOT VOTED: 419
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDona” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,10055,314 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).

Elect Director: Lawrence Kurzius

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 442,964,897AGAINST: 24,863,542
Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Kurzius

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Lawrence Kurzius”): 442,964,897 for, 24,863,542 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 280,823,996 for, 7,771,416 against, 82,173 abstained, 419 not voted.

FOR
FOR: 280,823,996AGAINST: 7,771,416ABSTAIN: 82,173NOT VOTED: 419
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Ku” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,10555,309 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).

Elect Director: Michael Harrington

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST
FOR: 373,406,333AGAINST: 94,421,261
Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Harrington

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Michael Harrington”): 373,406,333 for, 94,421,261 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 227,513,435 for, 61,081,977 against, 82,173 abstained, 419 not voted.

FORAGAINST
FOR: 227,513,435AGAINST: 61,081,977ABSTAIN: 82,173NOT VOTED: 419
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Har” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,578,31385,101 00For
Dodge & Cox053,024,253 00Against
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).

By non-binding vote, the compensation of Elanco's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

82% Approved · of votes cast

FOR 82%AGAINST
FOR: 383,528,222AGAINST: 84,173,798

Prior year: 53.5% for (May 16, 2025 meeting) ▲ 28.5 pts

Details: description as filed, official tally, votes by 500 asset managers

Description as filed by funds: Advisory vote on the compensation of the company's named executive officers.

Elanco Animal Health Incorporated’s own tally for this item (“3. By non-binding vote, the compensation of Elanco's named executive officers”): 383,528,222 for, 84,173,798 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 110 asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,663,229185 00For
Dodge & Cox053,024,253 00Against
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,042,661183,198 00For
Dimensional6,874,2620 00For
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco05,773,017 00Against
Bridge Builder Trust4,679,9780 00For
New York Life4,073,75762,244 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,277,4750 00For
Legg Mason2,500,0000 00For
Jackson National2,498,1570 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,583,3210 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Fund voting reports, all 110 managers: 228,041,352 for, 60,336,759 against, 82,173 abstained, 419 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 417 asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Dodge & Cox064,973,931 00Against
Fidelity45,721,77583,976 00For
PRIMECAP MANAGEMENT CO/CA/43,001,3070 00For
T. Rowe Price35,201,835274,522 00For
GEODE CAPITAL MANAGEMENT, LLC11,088,5290 00For
Black Creek Investment Management Inc.10,032,2660 00For
BlackRock9,781,019204,984 00For
State Street9,770,40111,988 00For
Invesco06,085,653 00Against
John Hancock5,845,2860 00For
FULLER & THALER ASSET MANAGEMENT, INC.5,648,9040 00For
Clearbridge Investments, LLC4,280,7890 00For
Vanguard3,948,3330 00For
Charles Schwab3,931,5480 00For
BARROW HANLEY MEWHINNEY & STRAUSS LLC3,475,2830 00For
JUPITER ASSET MANAGEMENT LTD3,427,5970 00For
Capital Group3,408,3580 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC2,823,6710 00For
Allspring2,722,1770 00For
Artemis Investment Management LLP02,623,844 00Against
Northern Trust2,415,53341,845 00For
SHAPIRO CAPITAL MANAGEMENT LLC2,401,5590 00For
MELLON INVESTMENTS Corp2,265,0270 00For
Federated Hermes2,122,76369,609 00For
Wellington2,174,4160 00For

Institutional-manager reports, all 417 managers: 250,108,579 for, 79,780,290 against, 37 abstained, 143,892 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.5% Approved · of votes cast

FOR 99.5%
FOR: 480,470,647AGAINST: 2,611,450

Prior year: 99.3% for (May 16, 2025 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.

Elanco Animal Health Incorporated’s own tally for this item (“2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026”): 480,470,647 for, 2,611,450 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026, by the votes set forth in the table below.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 288,521,273 for, 129,770 against, 82,173 abstained, 419 not voted.

FOR
FOR: 288,521,273AGAINST: 129,770ABSTAIN: 82,173NOT VOTED: 419
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,15655,258 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional6,874,2620 00For
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,277,4750 00For
Legg Mason2,500,0000 00For
Jackson National2,498,1570 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,583,3210 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica913,2600 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 113 asset managers. All 113 are in the interactive database (link above).

Largest Elanco Animal Health Incorporated shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 499,449,583 shares outstanding at the time of that meeting.

Fund voting reports: top Elanco Animal Health Incorporated shareholders by shares voted on “Advisory vote on the compensation of the company's named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 16.15%
2Dodge & Cox 10.62%
3Fidelity 9.53%
4BlackRock 4.26%
5T. Rowe Price 3.85%
6Dimensional 1.38%
7PRIMECAP Odyssey Funds 1.22%
8Invesco 1.16%
9Bridge Builder Trust 0.94%
10New York Life 0.83%
Institutional-manager reports: top Elanco Animal Health Incorporated shareholders by shares voted on “Advisory vote on the compensation of the company's named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Dodge & Cox 13.01%
2Fidelity 9.17%
3PRIMECAP MANAGEMENT CO/CA/ 8.61%
4T. Rowe Price 7.10%
5GEODE CAPITAL MANAGEMENT, LLC 2.22%
6Black Creek Investment Management Inc. 2.01%
7BlackRock 2.00%
8State Street 1.96%
9Invesco 1.22%
10John Hancock 1.17%

Reported Elanco Animal Health Incorporated holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Elanco Animal Health Incorporated holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Dodge & Cox68,944,100 13.80%Schedule 13G, filed May 14, 2026
FMR LLC52,196,321 10.45%Proxy statement (DEF 14A), table as of March 26, 2026
FMR (Fidelity)50,925,366 10.20%Form 13F, quarter ended March 31, 2026
Vanguard Group48,059,731 9.62%Form 13F, quarter ended March 31, 2026
BlackRock47,622,630 9.54%Form 13F, quarter ended March 31, 2026
PRIMECAP MANAGEMENT CO/CA/45,840,956 9.18%Schedule 13G, filed May 13, 2026
T. Rowe Price Investment Management, Inc.31,547,970 6.32%Proxy statement (DEF 14A), table as of March 26, 2026
Dimensional Fund Advisors LP25,082,545 5.02%Proxy statement (DEF 14A), table as of March 26, 2026
State Street15,336,479 3.07%Form 13F, quarter ended March 31, 2026
Morgan Stanley8,286,608 1.66%Form 13F, quarter ended March 31, 2026

Percentages above are of 499,449,583 shares outstanding, as reported by Elanco Animal Health Incorporated on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Elanco Animal Health Incorporated's shareholder meeting held May 21, 2026, in the 2025-2026 proxy season, 501 asset managers reported votes on at least one of its 7 ballot items in their SEC Form N-PX filings, covering 4,257 separate fund positions. On the most widely held item on that ballot — Advisory vote on the compensation of the company's named executive officers. — Elanco Animal Health Incorporated's filing reports the proposal as approved, with 82% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Elanco Animal Health Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Elanco Animal Health Incorporated’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Elanco Animal Health Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Elanco Animal Health (ELAN) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/elanco-animal-health-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.